U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
· 10/24/2026, 5:36:56 AM· 2 min read
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
Read original story →Related stories
breaking
T.N.-Keralam officials discuss arrangements ahead of Sabarimala season
breaking
Tamil Nadu Social Justice Dept. raises food allowance for students in hostels, residential schools
breaking
Haryana Police, CBI working to expedite deportation of gangster Himanshu Bhau from U.S.
breaking